ACRS R&D Expenses

Aclaris Therapeutics Inc · R&D Expenses

ACRS logo

ACRS R&D Expenses

Latest reported$64.12M
ACRS R&D Expenses ($3.49M → $64.12M)
High-resolution chart · PNG

ACRS r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aclaris Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
52,645,000
33,586,000
98,384,000
77,813,000
43,813,000
29,338,000
64,899,000
63,009,000
39,790,000
33,476,000
15,339,000
6,507,000
3,488,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.